Healthcare organisations should design interoperability around legal, clinical, and access-control requirements at the same time. Start with the most restrictive applicable rules, classify and segment data, and limit access through role-based permissions. Then define exactly which clinical workflows justify exchange, so information moves only where it improves care and stays compliant with privacy obligations.
How interoperability programs can share ePHI without weakening privacy
Interoperability only works when privacy is designed into the exchange, not added after the interfaces are live. The practical challenge is to let clinicians and systems move the minimum necessary information for a defined purpose, while keeping consent, segmentation, authentication, logging, and role boundaries strong enough that exchange does not become broad internal data sprawl.
Build the exchange around purpose, data class, and workflow
A safe interoperability program starts by separating the question of what can be shared from why it is being shared. That means mapping each data class to a legal and clinical basis for exchange, then limiting the data set to the fields that are actually needed for that workflow. If the workflow does not justify exposure, the integration should not exist.
For healthcare organisations, this usually means treating high-sensitivity categories differently from routine operational data. Demographic, scheduling, referral, and care-coordination exchanges may be routine, but behavioural health, reproductive health, substance-use information, and other sensitive records often need tighter handling, more explicit segmentation, or additional policy checks before they are exposed outside a narrow treatment path.
Exchange design also needs to assume that privacy failures often come from over-broad interfaces, not from the core clinical system itself. A good interoperability program makes the data contract explicit, so downstream systems receive only the fields they need, and role-based access can be enforced consistently across portals, APIs, and connected applications.
Control access at the identity, application, and network boundaries
Once the permitted exchange is defined, privacy depends on whether access controls actually follow that definition. The strongest pattern is layered control: authenticate the requesting user or system, enforce role-based permissions, segment by context or function, and log the exchange so the organisation can verify who accessed what, when, and under which workflow.
This is where many programs weaken. If clinicians, analysts, integration engines, and partner systems all use the same broad pathway, privacy controls become difficult to prove and difficult to audit. Interoperability should therefore distinguish between human users, service-to-service calls, and third-party connections, because each one carries a different risk profile and a different control design.
That control stack should be paired with least privilege and data minimisation. A receiving application should not automatically inherit full source-system visibility just because it is technically connected. The access rule should be narrower than the transport rule: the fact that a system can receive data does not mean it should receive all available data.
Design for governance, auditability, and change over time
Interoperability programs fail when they treat data sharing as a one-time integration project instead of a governed operating model. Privacy controls need ownership, review, and exception handling, because clinical workflows, partner relationships, and regulatory obligations change. A program that is secure at go-live can become over-permissive after new endpoints, new vendors, or new report formats are added.
Governance should therefore require a documented approval path for each exchange, periodic review of who still needs access, and evidence that the original purpose remains valid. It should also include audit trails that are usable by both security and privacy teams, so they can reconstruct not only whether access occurred, but whether it was appropriate for the clinical purpose that justified it.
Interoperability also needs a clean exception model. Emergency access, public health reporting, and care-transition scenarios can justify broader exchange, but those exceptions should be explicit, time-bounded, and reviewable rather than becoming the default architecture for every integration.
Risk and Threat Considerations
When interoperability expands without strong privacy controls, the main risk is not just accidental disclosure, but uncontrolled reuse of sensitive records across too many systems, roles, and partners. That creates a larger blast radius for misconfiguration, over-permissioned accounts, poor segmentation, and secondary use that was never intended by the originating clinical workflow.
Failure mechanism: Broad interface design, weak data minimisation, or shared access paths allow more users and systems than necessary to retrieve ePHI, so privacy controls degrade as integrations multiply.
Impact: The organisation can lose confidentiality, weaken compliance posture, and make it harder to prove that each disclosure was justified by the underlying treatment, operations, or reporting purpose.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 sets the technical controls, while GDPR defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | AC-3 — Access Enforcement | Interoperability must enforce role and purpose-based access to ePHI. |
| AU-2 — Event Logging | Exchange programs need auditability for disclosures and access review. | |
| IA-2 — Identification and Authentication (Organizational Users) | Users and systems must be authenticated before accessing shared health data. | |
| Recommendation — Enforce least-privilege access on every exchange path and workflow. Log ePHI exchanges with enough detail to reconstruct who accessed what and why. Require strong authentication for users and systems that request interoperable access. | ||
| GDPR | Art.5 — Principles relating to processing of personal data | Data minimisation and purpose limitation directly shape safe ePHI sharing. |
| Art.25 — Data protection by design and by default | Interoperability privacy controls should be built into the exchange architecture. | |
| Recommendation — Limit shared data to what is necessary for the stated processing purpose. Design the interface so privacy is the default and extra disclosure requires justification. | ||
Practitioner Guidance
What to prioritise: Start with the highest-risk exchanges, meaning the workflows that move sensitive data across organisational boundaries or into multiple downstream systems. Those are the integrations where purpose limitation, segmentation, and access review matter most.
What to verify: Confirm that each interface has an approved business purpose, a minimum data set, a named owner, and a reviewable access path. If you cannot explain why a field is being shared, it probably should not be in the payload.
What good looks like: Clinicians can exchange the data they need for care without giving every connected system broad visibility into the source record, and security teams can trace each disclosure back to a defined workflow and role.
Practitioner takeaway: The safest interoperability program is not the one with the most connections, it is the one with the clearest rules for who may exchange which data, for what purpose, and under what reviewable conditions.
Related resources from NHI Mgmt Group
- How should healthcare organisations implement interoperability without weakening privacy or consent controls?
- How should healthcare organisations govern FHIR API access without weakening interoperability?
- How should organisations handle EU Data Act data access and sharing requests without weakening privacy controls?
- How should organisations design a shared mobile strategy for frontline workers without weakening security controls?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 27, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
